The DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.
Marine Natural Products: A Source of Novel Anticancer Drugs
Open accessAbstract
Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.
Overview
CoChat Summary
TL;DR
This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.
Key findings
- Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
- The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
- Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
- ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.
Methods
- Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
- For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
- Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.
Limitations
- Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Partly supportedcites [6] Ang, 2000, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) says marine-sponge manzamines had attracted interest as potential anticancer agents and inhibited cancer-cell growth. It does not say that advanced technology produced a new generation of anticancer drugs or that any were in clinical trials; this paper reports antimalarial testing in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Natural bioactive molecules exhibit cytotoxic effects by attacking macromolecules expressed by cancer cells, such as those in oncogenic signal transduction pathways [16].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Supportedcites [16] Nobili, 2009, Natural compounds for cancer treatment and prevention, Pharmacol. Res. source
The Conclusions describe natural compounds with cytotoxic activity that target macromolecules in cancer cells, including compounds targeting oncogenic signal-transduction pathways. The citing sentence paraphrases that distinction. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past 50 years, emerging evidence has shown that many natural products derived from plants and microbes of marine origin (Table 1), exhibit beneficial effects in the prevention and treatment of cancer, i.e., cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine are marine-based drugs used against leukemia, metastatic breast cancer, soft tissue sarcoma and ovarian cancer [20,”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 2. Nature and Cancer Chemotherapy
What the sources say
- Partly supportedcites [20] Dyshlovoy, S.A., and Honecker, F. (2018). Marine compounds and cancer: 2017 updates. Mar. Drugs, 16. sourceExperimental — accuracy not yet measured
The paper’s main text reports anticancer activity in compounds from marine algae and microbes and identifies four marine-derived drugs approved to treat cancer. It does not establish beneficial effects in cancer prevention, so the prevention portion of the claim is unsupported. (LLM, conf=0.85)
- Not matchedcites [21] (2019, August 17). Drug Bank. Available online: http://www.drugbank.ca.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The bryostatin 1 has recently entered phase II clinical trial against melanoma, non-Hodgkin’s lymphoma, renal cancer and colorectal cancer [58,59,60].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs
What the sources say
- Not checked — no full text of the sourcecites [58] Bourhill, 2017, Enzastaurin: A lesson in drug development, Crit. Rev. Oncol. Hematol. source
- Partly supportedcites [59] Wang, 2013, Marine-derived angiogenesis inhibitors for cancer therapy, Mar. Drugs sourceExperimental — accuracy not yet measured
Section 4.1 reports phase I and II bryostatin-1 trials involving all four named cancers, and the References list phase II studies for each, including colorectal cancer (ref. 132). But the paper says more than 80 phase I and II trials had been conducted since 1993; it does not support the claim that bryostatin-1 had recently entered phase II trials. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [60] Ritchie, 2015, Cancer research UK centre for drug development: Translating 21st-century science into the cancer medicines of tomorrow, Drug Discov. Today source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
What the sources say
- Could not verifycites [107] Peng, 2010, Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum, J. Am. Chem. Soc. sourceExperimental — accuracy not yet measured
The Abstract describes karlotoxin-2 from the marine dinoflagellate Karlodinium veneficum and its toxicity to fish. Searches for benthic cyanobacteria and leukemia found no passage addressing their potential as a source of leukemia drugs. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
69 more claims · 15 with their cited sources checked
Create a free account to see all 110 claims and to verify the 12 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against KB cells and 5 µg/mL against LOVO cells (colon cancer)”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines”
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“In 2018, approximately 18 million new cases of cancer reported globally, resulting in approximately 10 million deaths [1].”
BackgroundCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 2×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundMedicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391 · cited 1×
“The incidence of cancer continues to increase due to environmental changes and life style modernization [3].”
BackgroundShahidi, F., Janitha, P. K., & Wanasundara, P. D. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527581 · Cited by 2,238
Research works printed but not linked: 7
- Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
- Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
- Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
- Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
- Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
- Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
- Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36
Cited by
Review on natural products databases: where to find data in 2020
Sorokina, M., & Steinbeck, C. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00424-9 · Cited by 485
“The Dictionary of Natural products (DNP) [25] and it’s autonomous sub-sections, the Dictionary of Marine Natural Products (DNMP) [28] and the Dictionary of Food Compounds [29], are the considered as the most complete and best-curated resources for NP. NaprAlert [30] was created by researchers at the University of Chic…”
BackgroundInfluentialMicroalgae: therapeutic potentials and applications
Khavari, F., Saidijam, M., Taheri, M., & Nouri, F. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06422-w · Cited by 257
“Bioactive compounds of blue-green algae can induce apoptosis and activate the protein kinase-c family in cancer cells [55].”
BackgroundReher, R., Kim, H. W., Zhang, C., Mao, H. H., Wang, M., Nothias, L.-F., Caraballo-Rodriguez, A. M., Glukhov, E., Teke, B., Leao, T., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13786 · Cited by 215
Biomaterials from the sea: Future building blocks for biomedical applications
Wan, M.-C., Qin, W., Lei, C., Li, Q.-H., Meng, M., Fang, M., Song, W., Chen, J.-H., Tay, F., & Niu, L.-N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.028 · Cited by 171
Self-citationCurcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment
Ghoran, S. H., Calcaterra, A., Abbasi, M., Taktaz, F., Nieselt, K., & Babaei, E. (2022) · Molecules · doi:10.3390/molecules27165236 · Cited by 160
“Due to their biochemical structures, natural compounds can affect numerous cellular targets, such as genes and proteins [4,5].”
BackgroundChang, W., Bow, Y., Fu, P.-J., Li, C., Wu, C., Chang, Y.-H., Teng, Y., Li, R., Lu, M., Liu, Y., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7689045 · Cited by 145
“Natural marine products have been found to have bioactivity against cancer progression [6, 7]; for example, makaluvamines, a group of pyrroloiminoquinone alkaloids isolated from marine sponges, have been identified to induce DNA cleavage [8] and protect against skin cancer [9] and lung cancer [10].”
BackgroundMarine-derived drugs: Recent advances in cancer therapy and immune signaling
Saeed, A. F. U. H., Su, J., & Ouyang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111091 · Cited by 149
Self-citationMetabolites with Antioxidant Activity from Marine Macroalgae
Tziveleka, L., Tammam, M. A., Tzakou, O. A., Roussis, V., & Ioannou, E. (2021) · Antioxidants · doi:10.3390/antiox10091431 · Cited by 143
Okeke, E. S., Ejeromedoghene, O., Okoye, C. O., Ezeorba, T. P. C., Nyaruaba, R., Chukwudozie, K. I., Oladipo, A., & Orege, J. I. (2022) · Energy Conversion and Management X · doi:10.1016/j.ecmx.2022.100323 · Cited by 220
Marine Cyanobacteria and Microalgae Metabolites—A Rich Source of Potential Anticancer Drugs
Mondal, A., Bose, S., Banerjee, S., Patra, J. K., Malik, J., Mandal, S. K., Kilpatrick, K. L., Das, G., Kerry, R. G., Fimognari, C., et al. (2020) · Marine Drugs · doi:10.3390/md18090476 · Cited by 126
Study of marine microorganism metabolites: new resources for bioactive natural products
Barzkar, N., Сухих, С. А., & Babich, O. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1285902 · Cited by 139
Bioactive Metabolites from Terrestrial and Marine Actinomycetes
Ngamcharungchit, C., Chaimusik, N., Panbangred, W., Euanorasetr, J., & Intra, B. (2023) · Molecules · doi:10.3390/molecules28155915 · Cited by 151
“Since 1980, biotechnology initially provided direction to study marine microorganisms for various applications such as drug development [34].”
BackgroundViswanathan, S., Palaniyandi, T., Kannaki, P., Rajeshkumar, S., Baskar, G., Rahaman, A. M., Paul, L. T. D., Rajendran, B. K., & Sivaji, A. (2022) · Particulate Science And Technology · doi:10.1080/02726351.2022.2074926 · Cited by 119
“In general, marine plants are indeed an amazing source of medically active substances with anti-oxidant and anti-tumor impacts (Khalifa et al. 2019).”
BackgroundLobine, D., Rengasamy, K. R. R., & Mahomoodally, M. F. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1893643 · Cited by 108
“For instance, in the last decade, approximately 2500 peptides with anti-proliferative activity have been identified from a wide range of marine flora (Khalifa et al. 2019).”
BackgroundYosri, N., Khalifa, S. A. M., Guo, Z., Xu, B., Zou, X., & El-Seedi, H. R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.229 · Cited by 94
“…biological constituents, among them are proteins, polypeptides, carbohydrates, polyphenols, polysaccharides, polymers, alkaloids, and pigments [23], and could be employed as potential bio-reducing, capping and stabilizing agents in one-step bioengineering of nanostructures including NPs [24]…”
BackgroundSelf-citationRecent Advances in Small Peptides of Marine Origin in Cancer Therapy
Zhang, Q., Liu, Z.-D., Wang, Z., Wang, T., Wang, N., Wang, N., Zhang, B., & Yu-fen, Z. (2021) · Marine Drugs · doi:10.3390/md19020115 · Cited by 76
“Additionally, it is gradually becoming a vital field of drug development [29].”
BackgroundNguyen, C. T., Dhakal, D., Pham, V. T. T., Nguyen, H. T., & Sohng, J. K. (2020) · Microorganisms · doi:10.3390/microorganisms8040616 · Cited by 92
“Similarly, various species of Streptomyces, have been characterized as major producers of anticancer drugs [8].”
BackgroundMarine Biocompounds for Neuroprotection—A Review
Bălașa, A. F., Chircov, C., & Grumezescu, A. M. (2020) · Marine Drugs · doi:10.3390/md18060290 · Cited by 81
“In this context, natural compounds represent the main treatment strategy for 87% of human diseases [3], with 63% of the newly developed drugs being categorized as naturally derived, either modified natural products, unmodified natural products, or synthetic products with a natural compound as the pharmacophore.”
BackgroundLopes, D., Melo, T., Rey, F., Meneses, J., Monteiro, F. L., Helguero, L. A., Abreu, H., Lillebø, A. I., Calado, R., & Domingues, M. R. (2020) · Molecules · doi:10.3390/molecules25173883 · Cited by 77
“Some metabolites from macroalgae such as lipids, sterols, terpenoids, pigments and phenolic compounds were tested as chemopreventive and anti-cancer agents [78,79].”
BackgroundMetabolomic tools used in marine natural product drug discovery
Stuart, K. A., Welsh, K., Walker, M. C., & Edrada‐Ebel, R. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1722636 · Cited by 75
“and chemically unique [7], it follows that the continued study of these organisms will lead to the discovery of a plethora of NPs with biologically active properties [8,9].”
BackgroundMarine Natural Products: A Potential Source of Anti-hepatocellular Carcinoma Drugs
Ren, X., Xie, X., Chen, B., Liu, L., Jiang, C., & Qian, Q. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02026 · Cited by 82
Wu, Y., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00790 · Cited by 77
Seaweed-Derived Sulfated Polysaccharides; The New Age Chemopreventives: A Comprehensive Review
Bhuyan, P. P., Nayak, R., Patra, S., Abdulabbas, H. S., Jena, M., & Pradhan, B. (2023) · Cancers · doi:10.3390/cancers15030715 · Cited by 93
Opportunities and challenges of fucoidan for tumors therapy
Yu, H., Zhang, Q., Farooqi, A. A., Wang, J., Yang, Y., Geng, L., & Wu, N. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121555 · Cited by 72
Oxidation and Antioxidation of Natural Products in the Model Organism Caenorhabditis elegans
Zhu, A., Zheng, F., Zhang, W., Li, L., Li, Y., Hu, H., Wu, Y., Bao, W., Li, G., Wang, Q., et al. (2022) · Antioxidants · doi:10.3390/antiox11040705 · Cited by 72
“clear magnetic resonance, atomic spectroscopy, circular dichroism spectrum, single crystal X-ray diffraction), the structures of these novel compounds can be resolved, making it possible to reveal the oxidation and antioxidation effects and mechanisms [14,15].”
BackgroundA propitious role of marine sourced polysaccharides: Drug delivery and biomedical applications
Sharma, A., Kaur, I., Dheer, D., Nagpal, M., Kumar, P., Venkatesh, D. N., Puri, V., & Singh, I. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120448 · Cited by 67
Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
Catanesi, M., Caioni, G., Castelli, V., Benedetti, E., d’Angelo, M., & Cimini, A. (2021) · Marine Drugs · doi:10.3390/md19010024 · Cited by 71
“Terpenes, shikimates, polyketides, acetogenins, peptides, alkaloids, and many uncharacterized structures, extracted and purified from marine resources [9], showed various pharmacological activities as antioxidant [10], antibacterial [11], anticancer [12], antiviral [13], anti-inflammatory [14], antidiabetic [15], anti…”
BackgroundMethodUrea-based anticancer agents. Exploring 100-years of research with an eye to the future
Listro, R., Rossino, G., Piaggi, F., Sonekan, F. F., Rossi, D., Linciano, P., & Collina, S. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.995351 · Cited by 61
Viswanathan, S., Palaniyandi, T., Rajeshkumar, S., Karunakaran, S., Pandi, M., Wahab, M. R. A., Baskar, G., Rajendran, B. K., Sivaji, A., & Moovendhan, M. (2023) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-023-03775-z · Cited by 64
“Seaweeds are often referred to as bio-nano factories due to the excellent capping and reducing features in nanomaterial fabrication and are less toxic and used as target drug carriers [10].”
Bilal, M., & Iqbal, H. M. N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.037 · Cited by 66
Monla, R. A., Dassouki, Z., Sari‐Chmayssem, N., Mawlawi, H., & Gali‐Muhtasib, H. U. (2022) · Molecules · doi:10.3390/molecules27020358 · Cited by 63
“Introduction The marine environment is an exceptionally diverse reservoir comprised of nearly 250,000 species that produce numerous secondary compounds with extraordinary chemical and pharmacological effects [1].”
BackgroundYak Milk: Nutritional Value, Functional Activity, and Current Applications
Wang, D., Zhou, Y., Zheng, X., Guo, J., Duan, H., Zhou, S., & Yan, W. (2023) · Foods · doi:10.3390/foods12112090 · Cited by 65
MAPK signaling pathway-targeted marine compounds in cancer therapy
Wei, J., Liu, R., Hu, X., Liang, T., Zhou, Z., & Huang, Z. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03460-y · Cited by 58
“1 3 past few decades, exceeding 200 new marine compounds that have been patented for important biological activities (Khalifa et al. 2019).”
BackgroundMethodKandasamy, G. D., & Kathirvel, P. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127256 · Cited by 72
Fahmy, N. M., & Abdel-Tawab, A. M. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00203-5 · Cited by 59
Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds
Chavda, V. P., Ertaş, Y. N., Walhekar, V. S., Modh, D. H., Doshi, A., Shah, N., Anand, K., & Chhabria, M. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702611 · Cited by 69
“Fragment-based drug discovery (FBDD) will have wide applications in the fi eld of natural products in the upcoming years because extraction, isolation, and puri fi cation of the active constituents from the natural sources are quite tedious and time-consuming (Khalifa et al., 2019).”
BackgroundTargeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer
Al‐Bari, M. A. A., Ito, Y., Ahmed, S. B. M., Radwan, N., Ahmed, H. S., & Eid, N. A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189807 · Cited by 56
A comprehensive review of anticancer mechanisms of action of Alantolactone
Babaei, G., Aziz, S. G., Bazl, M. R., & Ansari, M. H. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111231 · Cited by 56
Marine peptides in breast cancer: Therapeutic and mechanistic understanding
Ahmed, S., Mirzaei, H., Aschner, M., Khan, A., Al‐Harrasi, A., & Khan, H. Z. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112038 · Cited by 53
Anwar, S., Almatroudi, A., Alsahli, M. A., Khan, M. A., Khan, A. A., & Rahmani, A. H. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200705220307 · Cited by 58
Plant‐Derived Coumarins: A Narrative Review of Their Structural and Biomedical Diversity
Younes, A. H., & Mustafa, Y. F. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400344 · Cited by 59
Molecular Pathways of Genistein Activity in Breast Cancer Cells
Konstantinou, E. K., Gioxari, A., Dimitriou, M., Panoutsopoulos, G. I., & Panagiotopoulos, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105556 · Cited by 66
Therapeutic applications and biological activities of bacterial bioactive extracts
Abdelghani, Z., Hourani, N., Zaidan, Z., Dbaibo, G. S., Mrad, M., & Hage‐Sleiman, R. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02505-1 · Cited by 62
Marine Actinomycetes Associated with Stony Corals: A Potential Hotspot for Specialized Metabolites
Siro, G., Pipite, A., Christi, K., Srinivasan, S., & Subramani, R. (2022) · Microorganisms · doi:10.3390/microorganisms10071349 · Cited by 63
“Culture-independent studies have further proven that indigenous marine actinomycetes belong to the genera Streptomyces, Dietzia, Solwaraspora, Williamsia, Marinispora, Verrucosispora, Aeromicrobium, Salinispora, Salinibacterium and Rhodococcus [55,62].”
BackgroundInfluentialBahrami, Y., Bouk, S., Kakaei, E., & Taheri, M. N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929161 · Cited by 59
“Streptomyces and Micromonosporas have a high potential for research on antitumor and growth inhibitors compounds (Khalifa et al., 2019).”
BackgroundEbrahimi, B., Baroutian, S., Li, J., Zhang, B., Ying, T., & Lu, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1047026 · Cited by 58
A Comprehensive Update on the Bioactive Compounds from Seagrasses
Gono, C. M. P., Ahmadi, P., Hertiani, T., Septiana, E., Putra, M. Y., & Chianese, G. (2022) · Marine Drugs · doi:10.3390/md20070406 · Cited by 59
Angulo-Elizari, E., Henriquez-Figuereo, A., Morán‐Serradilla, C., Plano, D., & Sanmartín, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116249 · Cited by 57
Safaei, M., & Shishehbore, M. R. (2021) · Talanta · doi:10.1016/j.talanta.2021.122247 · Cited by 52
Zhao, M., Chen, S., Ji, X., Shen, X., You, J., Liang, X., Yin, H., & Zhao, L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105517 · Cited by 53
Bioactive Compounds from Marine Heterobranchs
Àvila, C., & Angulo‐Preckler, C. (2020) · Marine Drugs · doi:10.3390/md18120657 · Cited by 51
“Many natural compounds present cytotoxic effects against macromolecules expressed by cancer cells, such as in oncogenic signal transduction pathways, and display growth inhibition of human tumor cells [39,42,43,482].”
BackgroundInfluentialLi, X., Lin, B., Lin, Z., Ma, Y., Qu, W., Zheng, Y., Cui, L., Luo, H., & Luo, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-84380-w · Cited by 57
Exploring the Diversity of the Marine Environment for New Anti-cancer Compounds
Dayanidhi, D. L., Thomas, B. C., Osterberg, J. S., Vuong, M., Vargas, G., Kwartler, S. K., Schmaltz, E., Dunphy‐Daly, M. M., Schultz, T. F., Rittschof, D., et al. (2021) · Frontiers in Marine Science · doi:10.3389/fmars.2020.614766 · Cited by 55
Insights into Antimicrobial and Anti-Inflammatory Applications of Plant Bioactive Compounds
Mitropoulou, G., Stavropoulou, E., Vaou, N., Tsakris, Z., Voidarou, C. C., Tsiotsias, A., Tsigalou, C., Taban, B. M., Kourkoutas, Y., & Bezirtzoglou, E. (2023) · Microorganisms · doi:10.3390/microorganisms11051156 · Cited by 60
“In addition, natural origin medications account for 60% of anti-tumor and anti-infectious pharmaceuticals that are now on the market or in clinical trials [3].”
BackgroundDalisay, D. S., Tenebro, C. P., Sabido, E. M., Suarez, A. F. L., Paderog, M. J. V., Reyes-Salarda, R., & Saludes, J. P. (2024) · Marine Drugs · doi:10.3390/md22030114 · Cited by 53
Marine natural products as source of new drugs: an updated patent review (July 2018-July 2021)
Banerjee, P., Mandhare, A., & Bagalkote, V. S. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2012150 · Cited by 45
Kaur, R., Sood, A., Lang, D. K., Arora, R., Kumar, N., Diwan, V., & Saini, B. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220117105740 · Cited by 51
Ghallab, D. S., Shawky, E. M., Ibrahim, R. S., & Mohyeldin, M. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-12265-7 · Cited by 45
“Under current analysis condition, three dipeptides were detected in peaks (14, 25, 35) and shared similar fragmentation pathway fundamentally manifested by the concerted cleavage of the protonated amide bond linking two consecutive amino acids expelling N-terminal and C-terminal amino acid fragments20.”
BackgroundSon, H., & Kim, D. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.1.283 · Cited by 45
Marine natural products as a source of novel anticancer drugs: an updated review (2019–2023)
El-Seedi, H. R., Refaey, M. S., Elias, N., El-Mallah, M. F., Albaqami, F. F., Dergaa, I., Du, M., Salem, M. F., Tahir, H. E., Daglia, M., et al. (2025) · Natural Products and Bioprospecting · doi:10.1007/s13659-024-00493-5 · Cited by 55
Self-citationTrinidad-Calderón, P. A., Varela-Chinchilla, C. D., & García‐Lara, S. (2021) · Molecules · doi:10.3390/molecules26247453 · Cited by 51
“There are additional peptides with anticancer effects tested in vivo [189,190].”
BackgroundRecent advances in marine biotechnology
Chakraborty, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91240-2.00002-6 · Cited by 46
Hegazy, M. F., Dawood, M., Mahmoud, N., Elbadawi, M., Sugimoto, Y., Klauck, S. M., Mohamed, N. S., & Efferth, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153409 · Cited by 43
Self-citationMarine Algal Polyphenols as Skin Protective Agents: Current Status and Future Prospectives
Jayawardhana, H. H. A. C. K., Jayawardena, T. U., Sanjeewa, K. K. A., Liyanage, N. M., Nagahawatta, D. P., Lee, H.-G., Kim, J., & Jeon, Y. (2023) · Marine Drugs · doi:10.3390/md21050285 · Cited by 48
Promises of natural products as clinical applications for cancer
Deng, R., Zong, G., Wang, X., Yue, B.-J., Cheng, P., Tao, R., Li, X., Wei, Z., & Lu, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189241 · Cited by 52
Natural bioactive compounds from marine fungi (2017–2020)
Wang, H., Sun, S., Liu, M., Yan, M., Liu, Y.-F., Zhu, Z., & Zhang, Z. (2021) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2021.1947254 · Cited by 41
Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
Ahmed, S., Alam, W., Jeandet, P., Aschner, M., Alsharif, K. F., Saso, L., & Khan, H. Z. (2022) · Marine Drugs · doi:10.3390/md20080466 · Cited by 39
Wu, C., Lusvarghi, S., Hsiao, S.-H., Liu, T.-C., Li, Y., Huang, Y.-H., Hung, T., & Ambudkar, S. V. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01022 · Cited by 39
Sarker, S. D., Nahar, L., Miron, A., & Guo, M. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.02.001 · Cited by 38
Codium fragile Ameliorates High-Fat Diet-Induced Metabolism by Modulating the Gut Microbiota in Mice
Kim, J., Choi, J. H., Oh, T., Ahn, B.-J., & Unno, T. (2020) · Nutrients · doi:10.3390/nu12061848 · Cited by 42
Khursheed, M., Ghelani, H., Jan, R. K., & Adrian, T. E. (2023) · Marine Drugs · doi:10.3390/md21100524 · Cited by 43
“Bioactive compounds from marine sources have shown immunomodulatory effects [6], activity against diseases such as type 2 diabetes mellitus [7] or anti-cancer properties [8,9].”
BackgroundInsight into Antioxidant and Photoprotective Properties of Natural Compounds from Marine Fungus
Dao, D. Q., Phan, T. T. T., Nguyen, T. L. A., Trinh, P. T. H., Tran, T. T. V., Lee, J. S., Shin, H. J., & Choi, B.-K. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00964 · Cited by 35
Marine Anthraquinones: Pharmacological and Toxicological Issues
Greco, G., Turrini, E., Catanzaro, E., & Fimognari, C. (2021) · Marine Drugs · doi:10.3390/md19050272 · Cited by 46
“Indeed, all over the world, marine flora and fauna have been used for medical uses since ancient times [3].”
BackgroundCancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug
Ru, R., Guo, Y., Mao, J., Yu, Z., Huang, W. M., Cao, X., Hu, H., Meng, M., & Yuan, L. (2022) · Nutrients · doi:10.3390/nu14040786 · Cited by 43
“Marine creatures are an enriched ore of drug development; at least 10% of the marine organism extracts possess anti-tumor properties [7,8].”
BackgroundIt comes from the sea: macroalgae-derived bioactive compounds with anti-cancer potential
Nova, P., Gomes, A., & Costa-Pinto, A. R. (2023) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2023.2174068 · Cited by 37
“The discovery of compounds with anti-cancer potential is actively growing [9].”
BackgroundThe multifaceted roles of natural products in mitochondrial dysfunction
Chen, Q., Ruan, D., Shi, J., Du, D., & Bian, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1093038 · Cited by 51
Qayoom, H., Alkhanani, M., Almilaibary, A., Alsagaby, S. A., & Mir, M. A. (2023) · Medical Oncology · doi:10.1007/s12032-023-02067-w · Cited by 44
Han, E.-J., Choi, E.-Y., Jeon, S.-J., Lee, S., Moon, J.-M., Jung, S., & Jung, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813949 · Cited by 50
Biosynthesis and function of 7-deazaguanine derivatives in bacteria and phages
de Crécy‐Lagard, V., Hutinet, G., Cediel-Becerra, J. D. D., Yuan, Y., Zallot, R., Chevrette, M. G., Ratnayake, R. M. M. N., Jaroch, M., Quaiyum, S., & Bruner, S. D. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00199-23 · Cited by 37
Dyshlovoy, S. A., Kudryashova, E. K., Kaune, M., Makarieva, T. N., Shubina, L. K., Busenbender, T., Денисенко, В. А., Popov, R. S., Hauschild, J., Fedorov, S. N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66428-5 · Cited by 38
Sugumaran, A., Pandiyan, R., Kandasamy, P., Antoniraj, M. G., Navabshan, I., Balasubramaniyan, S., Dharmaraj, S., Chinnaiyan, S. K., Ashokkumar, V., & Ngamcharussrivichai, C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155445 · Cited by 39
Adedokun, K. A., Imodoye, S. O., Bello, I. O., Lanihun, A.-A. A., & Bello, I. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90593-0.00017-4 · Cited by 64
Eze, O. C., BEREBON, D. P., Emencheta, S. C., Evurani, S. A., Okorie, C. N., Balcão, V. M., & Vila, M. M. D. C. (2023) · Pharmaceuticals · doi:10.3390/ph16081091 · Cited by 36
“, Streptomyces staurosporeus, Saccharothrix aerocolonigenes, Caldora penicillata [75,76]”
BackgroundMarine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
Ferreira, I., Rauter, A. P., & Bandarra, N. M. (2022) · Marine Drugs · doi:10.3390/md20110662 · Cited by 42
Cytotoxic Polyketides Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum MCCC 3A00292
Niu, S., Xia, M., Chen, M., et al. (2019) · Marine Drugs · doi:10.3390/md17120686 · Cited by 33
Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms
Wu, L., Ye, K., Jiang, S., & Zhou, G. (2021) · Marine Drugs · doi:10.3390/md19090488 · Cited by 36
“There are 17 clinically available drugs that were based on marine natural products or their derivatives, and 28 drugs that are currently being tested in phase I–III clinical trials [4,5].”
BackgroundRinaldis, G. D., Leone, A., Domenico, S. D., Bosch‐Belmar, M., Šližytė, R., Milisenda, G., Santucci, A., Albano, C., & Piraino, S. (2021) · Marine Drugs · doi:10.3390/md19090498 · Cited by 38
Fang, Y., Li, H., Ji, B., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113092 · Cited by 32
Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
Zheng, J., Wang, J., Wang, Q., Zou, H., Wang, H., Zhang, Z., Chen, J., Wang, Q., Wang, P., Zhao, Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.001 · Cited by 37
Zhang, W., Zhu, Y., Yu, H., Liu, X., Jiao, B., & Lü, X. (2021) · Molecules · doi:10.3390/molecules26020315 · Cited by 32
“The particularity of the marine ecological environment (high pressure, high salt, and hypoxia) makes the secondary metabolites of marine microorganisms have unique structures with extensive biological activities, which may have profound effects for drug discovery and development [28].”
BackgroundLiu, M., Liu, F., Li, Y., Yin, J., Gao, Y., Wang, X., Yang, C., Liu, J., & Li, H.-J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5040326 · Cited by 37
Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells
Maniam, S., & Maniam, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189722 · Cited by 37
Srimongkol, P., Songserm, P., Kuptawach, K., Puthong, S., Sangtanoo, P., Thitiprasert, S., Thongchul, N., Phunpruch, S., & Karnchanatat, A. (2022) · Algal Research · doi:10.1016/j.algal.2022.102919 · Cited by 34
Marine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry
Akram, W., Rihan, M., Ahmed, S., Arora, S., Ahmad, S., & Vashishth, R. (2023) · Marine Drugs · doi:10.3390/md21030193 · Cited by 39
Review of the evidence for oceans and human health relationships in Europe: A systematic map
Short, R., Cox, D. T. C., Tan, Y. L., Bethel, A. C., Eales, J. F., & Garside, R. (2020) · Environment International · doi:10.1016/j.envint.2020.106275 · Cited by 36
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
Conte, M., Fontana, E., Nebbioso, A., & Altucci, L. (2020) · Marine Drugs · doi:10.3390/md19010015 · Cited by 39
“These genes are usually located in specific biosynthetic gene clusters (BGCs) in the genome [23] that contain the required enzymes responsible for synthesis of secondary metabolites and regulatory structures.”
BackgroundBioactive Heterocyclic Compounds as Potential Therapeutics in the Treatment of Gliomas: A Review
Hassan, R., Mohi-ud-din, R., Dar, M. O., Shah, A. J., Mir, P. A., Shaikh, M., & Pottoo, F. H. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210901112954 · Cited by 34
Terpenes extracted from marine sponges with antioxidant activity: a systematic review
Martignago, C. C. S., Soares‐Silva, B., Parisi, J. R., Souza-Silva, L. C., Granito, R. N., Ribeiro, A. M., Rennó, A. C. M., de Sousa, L. R. F., & Aguiar, A. C. C. (2023) · Natural Products and Bioprospecting · doi:10.1007/s13659-023-00387-y · Cited by 30
“In addition, isolated bioactive compounds from sponges with anticancer effects showed to prevent tumor formation and growth, and inducing cell death by apoptosis [6, 7].”
BackgroundAli, M. L., Noushin, F., Azme, E., Hasan, M. M., Hoque, N., & Metu, A. F. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00258-5 · Cited by 29
“…extensive searching of previously published litera - ture, a primary list of natural small molecules from marine sources that showed potent anti-cancer activities in vitro or in vivo was constructed (Ali et al. 2024a , 2024b ; Bar-reca et al. 2020 ; Khalifa et al. 2019 ; Veríssimo et al. 2021 ).”
Sofrona, E., Tziveleka, L., Harizani, M., Koroli, P., Sfiniadakis, I., Roussis, V., Rallis, M. C., & Ioannou, E. (2020) · Marine Drugs · doi:10.3390/md18040219 · Cited by 31
Metadata
- Authors
- Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
- Affiliations
- Karolinska University Hospital (SE)
- University of Kalamoon (SY)
- Cairo University (EG)
- Fujian Agriculture and Forestry University (CN)
- Quaid-i-Azam University (PK)
- Johannes Gutenberg University Mainz (DE)
- Kuwait University (KW)
- Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
- University of Karachi (PK)
- Kaohsiung Medical University (TW)
- Keio University (JP)
- Uppsala University (SE)
- Jiangsu University (CN)
- Corresponding author
- El-Seedi, Hesham R.
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 17
- Issue
- 9
- Pages
- 491
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6780632
- OpenAlex
- W2969876208
- Semantic Scholar
- fc04613de468c55e3c00acaa04bbf85967f96088
- Cited by
- 555
- References
- 235
- Citations by year
- 2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.